BioStem Technologies director reports 7,671 RSUs

BioStem Technologies, Inc. reported the initial beneficial ownership of director Steven D. Sonenreich in the form of restricted stock units (RSUs).

Rhea-AI Filing Summary

BioStem Technologies, Inc. reported the initial beneficial ownership of director Steven D. Sonenreich in the form of restricted stock units (RSUs). These RSUs represent rights to acquire 7,671 shares of common stock and vest on August 27, 2026, with each unit convertible into one share upon vesting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider SONENREICH STEVEN D

Role Director

Type	Security	Shares	Price	Value
holding	Restricted Stock Units F2, F1	--	--	--

Holdings After Transaction: Restricted Stock Units — 7,671 contracts (Direct)

Footnotes (2)

1. F1. These restricted stock units vest on August 27, 2026.
2. F2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

Key Figures

Underlying common shares: 7,671 shares RSU vesting date: August 27, 2026 Direct derivative holding: 1 position

3 metrics

Underlying common shares 7,671 shares Shares underlying restricted stock units reported as of the Form 3 filing

RSU vesting date August 27, 2026 Vesting date for reported restricted stock units

Direct derivative holding 1 position Restricted stock units held directly by the reporting person

Key Terms

Restricted Stock Units, contingent right, beneficial ownership

3 terms

Restricted Stock Units financial

"These restricted stock units vest on August 27, 2026."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each restricted stock unit represents a contingent right to receive one share"

beneficial ownership financial

"reported the initial beneficial ownership of director Steven D. Sonenreich"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider position did Steven D. Sonenreich report on Form 3 for BSEM?

Steven D. Sonenreich reported ownership of restricted stock units linked to BioStem Technologies, Inc. common stock. These RSUs are reported as a direct derivative holding and represent his initial beneficial ownership position as a director.

How many BioStem Technologies (BSEM) shares are covered by Sonenreich's RSUs?

The reported restricted stock units correspond to 7,671 underlying shares of BioStem Technologies common stock. Each RSU represents a contingent right to receive one share, subject to the vesting conditions described in the filing.

When do Steven D. Sonenreich’s RSUs in BSEM vest?

The restricted stock units reported by Steven D. Sonenreich vest on August 27, 2026. Once vested, each unit represents the right to receive one share of BioStem Technologies’ common stock, assuming all vesting conditions are satisfied.

Are Sonenreich’s BSEM restricted stock units a direct or indirect holding?

The filing classifies Steven D. Sonenreich’s restricted stock units as a direct holding. This means the RSUs are recorded in his name directly rather than through a trust, fund, or other indirect ownership vehicle.

Do the BSEM RSUs reported by Sonenreich have a stated exercise price or expiration?

The RSUs reported for Steven D. Sonenreich do not list an exercise price or expiration date. The footnotes state that each unit is a contingent right to receive one share of common stock upon vesting on August 27, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/14/2026 - 07:12 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

SONENREICH STEVEN D

(Last) (First) (Middle)

C/O BIOSTEM TECHNOLOGIES, INC.

2836 CENTER PORT CIRCLE

(Street)

POMPANO BEACH FLORIDA 33064

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
08/06/2026

3. Issuer Name and Ticker or Trading Symbol
BioStem Technologies, Inc. [ BSEM ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	(1)	Common Stock	7,671	(2)	D

Explanation of Responses:

1. These restricted stock units vest on August 27, 2026.

2. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.

	/s/ Steven D. Sonenreich	08/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)